anonymous
Guest
anonymous
Guest
Rumor has it.... ZS 9 ..... approved in May 2018 but not launched until 2019?
Rumor has it.... ZS 9 ..... approved in May 2018 but not launched until 2019?
So, actually Epanova is available OTC and the decision to not launch it was a business decision. AZN does not want to compete against OTCs, not very innovative, Vascepa (Amarin) selling about $175mm last year, not a hell of a whole lot for a big pharma company like AZN. ZS-9 is not in that league. Do your homework my friend. Looks like you have no clue about zs-9EPANOVA approved four years ago. Still not commercially available. Keep dreaming sweet cheeks.
So, actually Epanova is available OTC and the decision to not launch it was a business decision. AZN does not want to compete against OTCs, not very innovative, Vascepa (Amarin) selling about $175mm last year, not a hell of a whole lot for a big pharma company like AZN. ZS-9 is not in that league. Do your homework my friend. Looks like you have no clue about zs-9
I personally wouldn’t call a person an idiot, just misguided. I too don’t think ZS-9 will ever launch with AZ. It might under some smaller company who needs to move a product. CV will probably be decommissioned before ZS-9 hits any shelf in the USSo Frenchy paid how much for EPANOVA in order to make a business decision to “shelf it”? You are an idiot! ZS-9 will not launch. Business model is just as bad.
So Frenchy paid how much for EPANOVA in order to make a business decision to “shelf it”? You are an idiot! ZS-9 will not launch. Business model is just as bad.
They paid $323 million, but AZ launched it. What are you talking about?